LEPTIN于膿毒癥中是一種危重病人適合的生物標志嗎?-技術前沿-資訊-生物在線

女人与狗锁死了视频大全|霍金死亡过程恐怖视频|无节社团简谱季免费观看|六间房直播大厅|中文字幕欧美另类精品|久久人人玩人妻潮喷内射人人|亚洲国产一区二区三区在线观看

LEPTIN于膿毒癥中是一種危重病人適合的生物標志嗎?

作者:北京經緯博恒生物科技開發有限責任公司 2011-05-20T00:00 (訪問量:51314)

Leptin in sepsis: a well-suited biomarker in critically ill patients?
Bracho-Riquelme RL, Reyes-Romero MA.
SourceUniversidad Juárez del Estado de Durango, Facultad de Medicina, División de Estudios de Posgrado e Investigación, Azucenas 157, Fracc, Jardines de Durango, Durango, Dgo. CP., México. rudybracho@yahoo.com.mx

Abstract
The value of monitoring serum leptin in critically ill patients is important for early diagnosis and differentiation between sepsis and non-infectious systemic inflammatory response syndrome (SIRS). The early diagnosis of sepsis, the identification of its origin, and an adequate therapeutic management are crucial to overcome sepsis-associated mortality. Cytokine levels are an obvious choice as sepsis markers, since cytokines are key mediators of the inflammatory response to sepsis. Leptin, a hormone mainly generated by adipocytes, acts centrally in the hypothalamus to regulate body weight and energy expenditure. There is, however, strong evidence that leptin is also involved in cell-mediated immunity and cytokine crosstalk. The finding that a serum leptin threshold of 38 microg/l can distinguish between sepsis and non-infectious SIRS (sensitivity 91.2%, specificity 85%) is the major finding in the article by Yousef and colleagues (in this issue). Much remains to be learned about the precise mechanisms by which leptin signaling participates in sepsis and non-infectious SIRS. This knowledge will potentially contribute to new therapeutic approaches.


北京經緯博恒生物科技開發有限責任公司 商家主頁

地 址: 北京市海淀區萬壽路街道太平路甲40號22樓411(軍醫科院南門).廊坊經濟技術開發區翠微南道29號(生產基地)

聯系人: 李經理

電 話: 業務:010-68167058,手機:18210299625

傳 真: 010-68167058

Email:genwaybh@163.com

相關咨詢
ADVERTISEMENT